13-cis-retinoic acid causes patterning defects in the early embryonic rostral hindbrain and abnormal development of the cerebellum in the macaque.
BACKGROUND
We have previously reported that exposure of embryos to 13-cis-retinoic acid (cRA) results in an abnormal phenotype of the fetal cerebellum. In this study, we analyzed early changes in the cerebellar anlagen (midbrain-hindbrain junction) as well as lesions of the fetal cerebellar vermis after a teratogenic dosing regimen of cRA in the macaque model.


METHODS
We examined embryo coronal sections of the midbrain-hindbrain junction immunostained for Pax-2, Engrailed-2 (En-2) and Krox-20. To characterize the cerebellum foliation and fissure formation processes, we analyzed vermal cortical cell layer development and the number and depth of the major fissures on sagittal sections of fetal vermis. We also examined Purkinje cell development in vermal sections immunostained for CD3.


RESULTS
Compared with controls, there was a consistent truncation of the midbrain-hindbrain region of early embryos exposed to cRA. The cRA-induced fetal vermis lesions included inhibition in its anteroposterior growth, altered folial patterning, a general loss of prominence of the fissures accompanied by a total loss of sublobular fissures, and changes in cortical cell layer development. CD3(+) Purkinje cells were abnormally dispersed deep into the molecular layer in the vermis.


CONCLUSIONS
Our findings indicate that the effects of cRA on the developing cerebellum involve interference with the hierarchy of complex cellular and genetic interactions that lead to the growth and subdivision of the cerebellum into smaller units. The regional vermal defects may be related to early postnatal functional deficits.
California Regional Primate Research Center, University of California, One Shields Avenue, Davis, California 95616-8542, USA.
N
N
Makori
P E
PE
Peterson
A G
AG
Hendrickx
D000818:Animals; D002531:Cerebellum / Q000002:abnormalities / Q000187:drug effects* / Q000196:embryology; D005314:Embryonic and Fetal Development / Q000187:drug effects*; D005260:Female; D015474:Isotretinoin / Q000633:toxicity*; D008251:Macaca; D010641:Phenotype; D011247:Pregnancy; D012249:Rhombencephalon / Q000002:abnormalities / Q000187:drug effects* / Q000196:embryology; D013723:Teratogens
D013723:Teratogens; D015474:Isotretinoin